Recombinant Epithelial Junction Opener Protein for Enhanced Drug Penetration in Epithelial Tumors
Proactive Cancer Immunotherapies for Initial and Recurrent Disease
University of Washington
This proposal aims to break down a major barrier to treating ovarian cancer. This new approach will not only result in better outcomes for ovarian cancer patients but can also potentially be expanded to treat other patients with solid tumor cancers.
Institute for Systems Biology
This proposed program initially formalizes early detection strategies through deep characterizations of patients with ovarian, breast, and colorectal cancers, prior to selecting a set of cancer patients for clinical trial designed to intercept recurrent disease through the design and administration of personalized, tumor-specific vaccines.